Skip to content

Database of Interstitial Lung Diseases

Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00267800
Enrollment
100000
Registered
2005-12-21
Start date
2006-01-31
Completion date
Unknown
Last updated
2008-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Diseases

Keywords

Lung disease, Interstitial, Sarcoidosis, Pulmonary fibrosis

Brief summary

The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.

Detailed description

Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs. Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research. Study design: A prospective observational study Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals. Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file. Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies. Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.

Interventions

None listed

Sponsors

St. Antonius Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of an ILD, as stated by the American Thoracic Society (ATS)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026